Medtronic Cites FDAMA Clause In Late Hour Bid To Stop IPG Reclassification

FDA cannot retroactively apply Sec. 216 of the FDA Modernization Act and use data contained in a Medtronic Itrel premarket approval application in reclassifying implantable pulse generator for use in treating chronic intractable pain, Medtronic says.

More from Archive

More from Medtech Insight